TSVCX
Price
$11.27
Change
+$0.02 (+0.18%)
Updated
Jul 31 closing price
Net Assets
183.26M
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

TSVCX vs VSCIX

TSVCX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
TSVCX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TSVCX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. TSVCX (183M). VSCIX pays higher dividends than TSVCX: VSCIX (1.23) vs TSVCX (0.00). TSVCX was incepted earlier than VSCIX: TSVCX (23 years) vs VSCIX (29 years). TSVCX (2.39) is less costly to investors than VSCIX (0.03). TSVCX is a more actively managed with annual turnover of: 56.00 vs. VSCIX (17.00). TSVCX has a lower initial minimum investment than VSCIX: TSVCX (1000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. TSVCX (5.13). VSCIX return over 5 years is better than : 35.13 vs. TSVCX (-19.70).
TSVCXVSCIXTSVCX / VSCIX
Total Expense Ratio2.250.037,500%
Annual Report Gross Expense Ratio2.390.037,967%
Fund Existence23 years29 years-
Gain YTD14.18414.59197%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets183M189B0%
Annual Yield % from dividends0.001.23-
Returns for 1 year5.1322.5823%
Returns for 3 years-0.3143.44-1%
Returns for 5 years-19.7035.13-56%
Returns for 10 years-10.03156.07-6%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C